Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Study Number: 

I 201611

Phase: 
II
Trial categories: 
Lymphoma
Mantel Cell
Immunotherapy
Antibody therapy
Principal Investigator: